بدائل البحث:
significant risks » significant risk (توسيع البحث), significant results (توسيع البحث), significant role (توسيع البحث)
risks decrease » sizes decrease (توسيع البحث), visits decreased (توسيع البحث), rivers decreased (توسيع البحث)
less decrease » mean decrease (توسيع البحث), teer decrease (توسيع البحث), we decrease (توسيع البحث)
_ decrease » _ decreased (توسيع البحث), _ decreasing (توسيع البحث)
significant risks » significant risk (توسيع البحث), significant results (توسيع البحث), significant role (توسيع البحث)
risks decrease » sizes decrease (توسيع البحث), visits decreased (توسيع البحث), rivers decreased (توسيع البحث)
less decrease » mean decrease (توسيع البحث), teer decrease (توسيع البحث), we decrease (توسيع البحث)
_ decrease » _ decreased (توسيع البحث), _ decreasing (توسيع البحث)
-
1
Change in influenza vaccination uptake from May 2020 to October 2024 (weighted).
منشور في 2025الموضوعات: -
2
The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin...
منشور في 2025"…<p dir="ltr">HIV acquisition risk with norethisterone (NET) enanthate (NET-EN) is reportedly less than for depo-medroxyprogesterone acetate intramuscular (DMPA-IM). …"
-
3
Risk of acquiring SARS-CoV-2 infection in the household (children vs. adults).
منشور في 2025الموضوعات: -
4
-
5
-
6
-
7
Risk Illustration.
منشور في 2025"…However, patients prescribed P2Y12 antagonists (HR = 0.285, 95% CI: 0.135–0.603, p < 0.001), those with a GFR > 60 ml/min (HR = 0.314, 95% CI: 0.158–0.624, p < 0.001), and those with a higher ejection fraction (HR = 0.962, 95% CI: 0.939–0.986, p = 0.002) were less likely to experience SCD following CABG. A 1 kg/m2 increase in BMI is associated with a 6.4% increase in the risk of SCD. …"
-
8
Expression of high-risk CRLs and co-expression CRGs in the GBM cuproptosis model.
منشور في 2025الموضوعات: -
9
S1 Data -
منشور في 2024"…AA (OR = 3.016) and CA (OR = 2.130) genotypes were identified as risk factors for stage II. ERCC1 significantly decreased in processing of CWP. …"
-
10
Change in the genotypes of <i>ATM</i>, <i>ERCC1</i>, and <i>XRCC1</i>.
منشور في 2024"…AA (OR = 3.016) and CA (OR = 2.130) genotypes were identified as risk factors for stage II. ERCC1 significantly decreased in processing of CWP. …"
-
11
Risk of bias.
منشور في 2025"…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …"
-
12
-
13
-
14
-
15
Most common symptoms and frequency of appearance among IgG-positive patients.
منشور في 2025الموضوعات: -
16
-
17
Characteristics of patients with <i>ACE2ACE2</i> and <i>TMPRSS2</i> expression.
منشور في 2025الموضوعات: -
18
-
19
-
20